Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
954
-
Total 13F shares, excl. options
-
124,470,870
-
Shares change
-
-1,615,061
-
Total reported value, excl. options
-
$31,994,071,856
-
Value change
-
-$470,206,356
-
Put/Call ratio
-
91%
-
Number of buys
-
403
-
Number of sells
-
-456
-
Price
-
$257.01
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q3 2023
1,131 filings reported holding BIIB - BIOGEN INC. - COM as of Q3 2023.
BIOGEN INC. - COM (BIIB) has 954 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124,470,870 shares
of 146,614,676 outstanding shares and own 85% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16,012,566 shares), BlackRock Inc. (13,974,587 shares), VANGUARD GROUP INC (12,188,586 shares), STATE STREET CORP (6,865,654 shares), WELLINGTON MANAGEMENT GROUP LLP (5,374,310 shares), JPMORGAN CHASE & CO (4,985,752 shares), T. Rowe Price Investment Management, Inc. (4,754,991 shares), GEODE CAPITAL MANAGEMENT, LLC (3,236,887 shares), Clearbridge Investments, LLC (1,823,182 shares), and NORTHERN TRUST CORP (1,643,035 shares).
This table shows the top 954 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.